Iperionx Stock Price, News & Analysis

IperionX (NASDAQ: IPX) has secured a significant SBIR Phase III contract from the U.S. Department of Defense worth up to US$99 million. The Indefinite Delivery, Indefinite Quantity (IDIQ) contract focuses on achieving Low-Cost Domestic Titanium for Defense Applications. The contract enables IperionX to receive task order funding from DoD agencies, with initial projects focusing on manufacturing high-performance titanium fasteners. The SBIR Phase III status indicates the technology's readiness to transition from R&D to scaled production. Production will occur at IperionX's Titanium Manufacturing Campus in Virginia, supporting local jobs and strengthening the U.S. defense industrial base. The contract aligns with U.S. Government priorities to enhance domestic critical-material manufacturing capabilities.

IperionX (NASDAQ: IPX) reported significant progress in Q1 2025 with its Titanium Manufacturing Campus in Virginia. The company expects full system operational capacity by mid-2025, with its HAMR™ furnace successfully producing high-quality titanium. Key achievements include: $47.1 million DoD funding for titanium supply chain development, $11.0 million from U.S. Export-Import Bank for equipment, and partnerships with eight commercial partners. The company is advancing its Titan Critical Minerals Project, the largest mineral sands project in the U.S., with a DFS expected in Q2 2026. The project aims to secure titanium feedstock and heavy rare earths supply. IperionX maintained a strong financial position with $66.1 million in cash as of March 31, 2025.

IperionX (NASDAQ: IPX) reported significant progress in its March 2025 quarterly update, highlighting the advancement of its Titanium Manufacturing Campus in Virginia. The facility is expected to reach full operational capacity by mid-2025, with the HAMR™ furnace successfully producing high-quality titanium exceeding industry standards.

The company secured substantial government support, including up to $47.1 million in U.S. Department of Defense funding and an additional $11.0 million from the U.S. Export-Import Bank. IperionX is actively working with eight commercial partners across defense, automotive, and consumer electronics sectors.

The company plans to expand titanium production capacity by the end of 2026, with expansion plans to be released mid-2025. A Definitive Feasibility Study for the Titan Critical Minerals Project, the largest critical mineral sands project in the U.S., is expected to complete in Q2 2026. As of March 31, 2025, IperionX maintained a strong financial position with US$66.1 million in cash.

IperionX (NASDAQ: IPX) has initiated a Definitive Feasibility Study (DFS) for its Titan Critical Minerals Project in Tennessee, marking a significant step toward developing a fully integrated U.S. titanium supply chain. The project represents the largest U.S. mineral resource of titanium, zircon, and rare earth mineral sands.

The DFS, expected to complete by Q2 2026, is partially funded through IperionX's recent US$47.1 million U.S. Government award. Total U.S. Government funding received since January 2023 exceeds US$60 million. The study will encompass detailed mine engineering, processing flowsheet, and infrastructure design.

The Titan Project could become the largest domestic source of critical heavy rare earth elements, including dysprosium and terbium, essential for advanced technologies and national defense. The company's Virginia Titanium Production Facility remains on schedule for ramp-up through 2025.

IperionX (NASDAQ: IPX) has secured approval from the U.S. EXIM Bank Board for an $11 million equipment finance loan to expand its advanced titanium manufacturing capabilities. The funding will be used to acquire state-of-the-art manufacturing equipment, including advanced additive manufacturing systems and precision machining tools at its Advanced Manufacturing Center in Virginia.

The financing aligns with EXIM Bank's 'Make More in America Initiative' and 'China and Transformational Exports Program', aimed at strengthening U.S. manufacturing capabilities and reducing foreign supply chain dependencies. This non-dilutive funding will support IperionX's mission to establish a fully integrated, end-to-end titanium supply chain within the United States, addressing critical supply gaps in industries such as aerospace, defense, automotive, and healthcare.

IperionX (NASDAQ: IPX) has released its Interim Financial Report for the six-month period ending December 31, 2024. The key highlight of this period was the commencement of titanium metal production at the company's Titanium Manufacturing Campus located in Halifax County, Virginia. This development marks a significant step in establishing a domestic, 'all-American' titanium supply chain.

IperionX (NASDAQ: IPX, ASX: IPX), a leading American titanium metal and critical materials company, has announced two significant board appointments effective March 17, 2025. Tony Tripeny joins as Non-Executive Director, bringing over 40 years of financial and operational leadership experience, including a 36-year career at Corning Incorporated where he served as Executive Vice President and Chief Financial Officer until 2022.

Additionally, current Non-Executive Director Lorraine Martin has been appointed as Lead Independent Director. Martin brings over 35 years of aerospace and defense industry experience from her executive roles at Lockheed Martin, including leadership of the F-35 Lightning II Program. She currently serves as President and CEO of the National Safety Council.

IperionX (NASDAQ: IPX) has been awarded a $47.1 million contract by the U.S. Department of Defense (DoD) to strengthen domestic titanium supply chains. The strategic partnership represents a total investment of $70.7 million over two years, combining DoD funding with IperionX's contribution.

The initial phase includes $5 million from DoD and $1 million from IperionX to advance the Titan Critical Minerals Project in Tennessee to 'shovel-ready' status. The remaining $42.1 million will support vertical integration and increased production capacity at IperionX's Titanium Manufacturing Campus in Virginia.

IperionX's proprietary technologies, HAMR™ and HSPT™, offer a pathway to produce low-cost, high-performance titanium, addressing the current import-dependent supply chain for titanium materials critical to aerospace, defense, automotive, and other industries.

IperionX (NASDAQ: IPX, ASX: IPX) has released a shareholder letter highlighting its achievements in 2024 and outlining plans for 2025. The company reports transformational progress in developing its Virginia Titanium Campus and accelerating innovation activities. The focus is on rebuilding America's titanium manufacturing industry through revolutionary, cost-effective, and energy-efficient technologies.

The company aims to establish domestic titanium production capabilities in the United States, leveraging breakthrough technologies to manufacture high-performance titanium products.